-0.000419243265905018 -0.000723194633686254 -0.00215910281941103 -0.00263075149355413 -0.00141494602242954 0.00119484330782935 -0.00398281102609785 -0.00177696258253847
Sign Up Today X
Thanks for submitting the form.
Stockreport

Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated (VRTX)  More Company Research Source: Yahoo! Finance
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
With a market cap of $122.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a leading biotechnology company focused on discovering, developing, and commercializing transformative medicines for serious diseases, particularly in areas of high unmet medical need. Founded in 1989 and headquartered in Boston, Massachusetts, Vertex is best known for building the first and dominant class of therapies that treat the underlying cause of cystic fibrosis (CF), establishing a durable global franchise with blockbuster drugs such as Trikafta/Kaftrio. Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Vertex fits this criterion perfectly, exceeding the mark. More News from Barchart As Nvidia Launches New AI Laptop Chips, Should You Buy NVDA Stock? 3 Highest Rated Dividend Kings for Generations of Income GE Aerospace Is Linking Up with Palantir. Should You Buy GE Stock Here? Tired of missing midday reversals? The FREE Barchart Brief newsletter [Read more]
IMPACT SNAPSHOT EVENT TIME: VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VRTX alerts
from News Quantified
VRTX
NEWS
VRTX
Earnings
VRTX
Analyst Actions
VRTX
SEC Filings
Stockreport

Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]

Vertex Pharmaceuticals Incorporated  (VRTX) 
More Company Research Source: Yahoo! Finance
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
With a market cap of $122.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a leading biotechnology company focused on discovering, developing, and commercializing transformative medicines for serious diseases, particularly in areas of high unmet medical need. Founded in 1989 and headquartered in Boston, Massachusetts, Vertex is best known for building the first and dominant class of therapies that treat the underlying cause of cystic fibrosis (CF), establishing a durable global franchise with blockbuster drugs such as Trikafta/Kaftrio. Companies valued at $10 billion or more are generally considered "large-cap" stocks, and Vertex fits this criterion perfectly, exceeding the mark. More News from Barchart As Nvidia Launches New AI Laptop Chips, Should You Buy NVDA Stock? 3 Highest Rated Dividend Kings for Generations of Income GE Aerospace Is Linking Up with Palantir. Should You Buy GE Stock Here? Tired of missing midday reversals? The FREE Barchart Brief newsletter [Read more]
IMPACT SNAPSHOT
EVENT TIME:
VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS